0.8338USD-3.82%Mkt Cap: 157.10M USDP/E: —Last update: 2026-06-01
Heron Therapeutics, Inc., a commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer,…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap157.10M USD
Enterprise Value262.59M USD
Revenue (TTM)150.71M USD
Gross Profit113.56M USD
Net Income (TTM)-20.20M USD
Revenue/Share0.8580 USD
Last Price0.8338 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees128
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS4277461020
Valuation
P/E (Trailing)—
P/E (Forward)Infinity
PEG—
EV/EBITDA-32.16
EV/Revenue1.74
P/S1.09
P/B20.23
EPS (TTM)-0.18
EPS (Forward)0.00
52W Range
0.74006% of range2.300
52W High2.300 USD
52W Low0.7400 USD
Profitability
Gross Margin73.31%
Oper. Margin-13.73%
EBITDA Margin-5.42%
Profit Margin-13.04%
ROE-140.90%
ROA-7.89%
Growth
Revenue Growth-10.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-27.59M USD
CapEx (TTM)317.00K USD
FCF Margin-12.24%
FCF Yield-11.74%
Net Debt96.85M USD
Net Debt/EBITDA-11.86
Balance Sheet
Debt/Equity9.81
Current Ratio2.53
Quick Ratio1.42
Book Value/Sh0.0430 USD
Cash/Share0.2370 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateJan 13, 2014
Analyst Consensus
Rating—
Target (Mean)3.667 USD
Target Range3.000 USD – 4.000 USD
# Analysts3
Ownership
Shares Out.189.28M
Float135.48M
Insiders0.88%
Institutions83.29%
Short Interest
Short Ratio15.6d
Short % Float26.72%
Short % Out.20.96%
Shares Short39.68M
Short (prev mo.)41.15M
Technical
SMA 500.9504 (-12.3%)
SMA 2001.174 (-29.0%)
Beta1.71
S&P 52W Chg27.94%
Avg Vol (30d)2.27M
Avg Vol (10d)1.74M
Technical Indicators
RSI (14)39.0
MACD-0.0481
MACD Signal-0.0358
MACD Hist.-0.0123
BB Upper1.341 USD
BB Middle0.9948 USD
BB Lower0.6486 USD
BB Width69.60%
ATR (14)0.0651 USD
Vol Ratio (20d)0.62x